Hot Two Shares to Ponder On: DaVita Inc. (NYSE:DVA), Abbott Laboratories (NYSE:ABT)

nyse

DaVita Inc. (NYSE:DVA)

DaVita Inc. (NYSE:DVA) closed at $76.08 on the last trading session with an increase of 9.86%, whereas, it previously closed at $69.25. The company has a market capitalization of $12.86 Billion. The company traded shares of 6.24 Million on the trading day while its three month average volume stands at 1.52 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of DaVita Inc. (NYSE:DVA) produced diluted EPS of 2.54. The EPS estimate for next year as estimated by analysts is at 5 while EPS for next quarter is estimated at 0.87. Earnings per Share growth for this year is reported at -32.2, while the analysts estimated the EPS growth for next year at 5% and Earnings growth for next 5 years stands at 23% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 4.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of DaVita Inc. (NYSE:DVA) is at 29.93 while the forward p/e is at 15.22. The P/S or Price to Sales ratio of DaVita Inc. (NYSE:DVA) stands at 1.14 and Price to Book or P/B for the most recent quarter stands at 3.05. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of DaVita Inc. (NYSE:DVA) are reported at 1.9 and 1.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for DaVita Inc. (NYSE:DVA) stands at 0, 0 and 8.8 respectively

The trailing twelve month Revenue of DaVita Inc. (NYSE:DVA) is reported at 11.28 Billion with income of 446.3 Million. The outstanding shares of DaVita Inc. (NYSE:DVA) are 169.05 Million. The institutional Ownership of the shares of 91.8 stands at 0.80%, this figure is decreased -0.21 in the last six months. The insider ownership for the shares of DaVita Inc. (NYSE:DVA) is ticked at 0.2%, the figure is plummeted -0.91% in the last six months.

Some other important financial aspects to be discussed here for DaVita Inc. (NYSE:DVA) is the Mean Target Price estimated by the analysts which stands at 80.75. The 52 week high of DaVita Inc. (NYSE:DVA) is placed at 80.71 and 52 week low is standing at 52.51.

Performance wise the shares of DaVita Inc. (NYSE:DVA) rose up 12.98% for the week, it also rise 1.66% for the monthly performance, while for the quarter it went down 4.72%. The shares increase 15.68% for the half year and flew up for the Year-To-Date performance. The shares of DaVita Inc. (NYSE:DVA) grew 29.04% for the yearly performance.

Abbott Laboratories (NYSE:ABT)

Abbott Laboratories (NYSE:ABT) closed at $72.5 on the last trading session with an increase of 2.17%, whereas, it previously closed at $70.96. The company has a market capitalization of $127.12 Billion. The company traded shares of 6.24 Million on the trading day while its three month average volume stands at 6.06 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Abbott Laboratories (NYSE:ABT) produced diluted EPS of 1.32. The EPS estimate for next year as estimated by analysts is at 3.2 while EPS for next quarter is estimated at 0.81. Earnings per Share growth for this year is reported at 44.6, while the analysts estimated the EPS growth for next year at 3.2% and Earnings growth for next 5 years stands at 11.47% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 47.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Abbott Laboratories (NYSE:ABT) is at 54.92 while the forward p/e is at 22.63. The P/S or Price to Sales ratio of Abbott Laboratories (NYSE:ABT) stands at 4.18 and Price to Book or P/B for the most recent quarter stands at 4.15. The Price to Free Cash Flow ratio or P/FCF is reported at 42.94. The quick ratio and the current ratio of Abbott Laboratories (NYSE:ABT) are reported at 1.1 and 1.4 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Abbott Laboratories (NYSE:ABT) stands at 1.2, 2.9 and 2.2 respectively

The trailing twelve month Revenue of Abbott Laboratories (NYSE:ABT) is reported at 30.4 Billion with income of 2.33 Billion. The outstanding shares of Abbott Laboratories (NYSE:ABT) are 1.75 Billion. The institutional Ownership of the shares of 74.9 stands at 0.80%, this figure is increased 0.16 in the last six months. The insider ownership for the shares of Abbott Laboratories (NYSE:ABT) is ticked at 0.3%, the figure is plummeted -6.84% in the last six months.

Some other important financial aspects to be discussed here for Abbott Laboratories (NYSE:ABT) is the Mean Target Price estimated by the analysts which stands at 78.94. The 52 week high of Abbott Laboratories (NYSE:ABT) is placed at 74.15 and 52 week low is standing at 54.32.

Performance wise the shares of Abbott Laboratories (NYSE:ABT) rose up 5.16% for the week, it also rise 1.7% for the monthly performance, while for the quarter it went down 12.16%. The shares increase 19.72% for the half year and flew up for the Year-To-Date performance. The shares of Abbott Laboratories (NYSE:ABT) grew 31.44% for the yearly performance.